Silhouette of six people on a mountain.

Our team uses datasets from varying health systems, commercial, and claims databases, including Department of Veteran Affairs data, Medicare data, and Optum data, to achieve the above goal. Our datasets include Race, Ethnicity, and Anticoagulation Choice in Atrial Fibrillations (REACH-AF), a national dataset of over 180,000 Veterans with Atrial Fibrillation that our team created. 

Our projects to date have included describing inequities in the use of newer direct oral anticoagulants (DOACs), examining varying facility level prescribing OAC therapies, and understanding how such disparities influence AF outcomes.

Collaborators

  • Michael Fine
  • Leslie Hausmann
  • Walid Gelad
  • Donna Washington
  • Jared Magnani
  • Nadejda Kim
  • Maria Mor
  • Terrence Litam
  • Taylor Boyer
  • Nicole Beyer
  • Kristina Hruska
  • Keri Rodriguez
  • Jasmyn Tang
  • Valerie Nguyen
  • Alison Hamilton

Publications

  1. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II
  2. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data
  3. Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System
  4. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities
  5. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines–Atrial Fibrillation Registry
  6. Veterans Affairs Medical Center Racial and Ethnic Composition and Initiation of Anticoagulation for Atrial Fibrillation
  7. Facility-Level Variation in Racial Disparities in Anticoagulation for Atrial Fibrillation: The REACH-AF Study